Argent Trust Co lessened its stake in shares of Danaher Co. (NYSE:DHR) by 2.1% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 27,614 shares of the conglomerate’s stock after selling 579 shares during the quarter. Argent Trust Co’s holdings in Danaher were worth $6,215,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors also recently modified their holdings of the company. Sterling Investment Advisors Ltd. acquired a new position in Danaher during the 1st quarter worth approximately $25,000. RMR Wealth Builders purchased a new stake in shares of Danaher during the fourth quarter valued at approximately $26,000. Inspire Advisors LLC purchased a new position in shares of Danaher in the fourth quarter valued at $26,000. Hudock Inc. grew its holdings in Danaher by 526.3% during the 4th quarter. Hudock Inc. now owns 119 shares of the conglomerate’s stock valued at $26,000 after purchasing an additional 100 shares in the last quarter. Finally, SOA Wealth Advisors LLC. purchased a new stake in Danaher during the 4th quarter worth $29,000. 77.57% of the stock is owned by institutional investors.
In other Danaher news, SVP Angela S. Lalor sold 3,092 shares of the firm’s stock in a transaction that occurred on Friday, April 23rd. The shares were sold at an average price of $255.79, for a total value of $790,902.68. Following the sale, the senior vice president now owns 30,937 shares in the company, valued at $7,913,375.23. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Joakim Weidemanis sold 17,169 shares of Danaher stock in a transaction that occurred on Tuesday, April 27th. The shares were sold at an average price of $258.76, for a total value of $4,442,650.44. Following the sale, the executive vice president now directly owns 84,420 shares in the company, valued at approximately $21,844,519.20. The disclosure for this sale can be found here. In the last three months, insiders have sold 35,165 shares of company stock valued at $9,051,818. Corporate insiders own 11.40% of the company’s stock.
NYSE DHR traded up $0.36 during trading hours on Friday, reaching $246.62. The company’s stock had a trading volume of 69,377 shares, compared to its average volume of 2,557,610. The company has a debt-to-equity ratio of 0.55, a quick ratio of 1.70 and a current ratio of 2.05. The company has a 50-day moving average of $247.65. Danaher Co. has a 52 week low of $164.51 and a 52 week high of $261.43. The company has a market cap of $175.91 billion, a PE ratio of 38.98, a PEG ratio of 1.50 and a beta of 0.69.
Danaher (NYSE:DHR) last announced its quarterly earnings results on Wednesday, April 21st. The conglomerate reported $2.52 earnings per share for the quarter, topping analysts’ consensus estimates of $1.67 by $0.85. Danaher had a return on equity of 16.34% and a net margin of 19.17%. The business had revenue of $6.87 billion for the quarter, compared to analysts’ expectations of $6.12 billion. During the same period in the prior year, the firm earned $1.05 EPS. The business’s quarterly revenue was up 58.2% on a year-over-year basis. As a group, sell-side analysts forecast that Danaher Co. will post 8.91 EPS for the current fiscal year.
The business also recently announced a quarterly dividend, which will be paid on Friday, July 30th. Shareholders of record on Friday, June 25th will be paid a $0.21 dividend. This represents a $0.84 dividend on an annualized basis and a yield of 0.34%. The ex-dividend date of this dividend is Thursday, June 24th. Danaher’s payout ratio is 13.31%.
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables.
Further Reading: What is the role of the G-20?
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.